Detalles de la búsqueda
1.
Overweight and obesity in polycystic ovary syndrome: association with inflammation, oxidative stress and dyslipidaemia.
Br J Nutr
; 128(4): 604-612, 2022 08 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34511137
2.
Evaluation of a Summary Score for Dyslipidemia, Oxidative Stress and Inflammation (the Doi Score) in Women with Polycystic Ovary Syndrome and its Relationship with Obesity.
J Med Biochem
; 37(4): 476-485, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30584408
3.
Direct intramuscular fetal or maternal antenatal corticosteroid therapy: short-time effects on fetal behavior and oxygenation: a comparative study.
J Matern Fetal Neonatal Med
; 29(19): 3213-7, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26572588
4.
Lipid accumulation product as a marker of cardiometabolic susceptibility in women with different phenotypes of polycystic ovary syndrome.
Eur J Endocrinol
; 175(6): 551-560, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27634940
5.
Lipid accumulation product is associated with metabolic syndrome in women with polycystic ovary syndrome.
Hormones (Athens)
; 15(1): 35-44, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26188230
6.
The influence of combined oral contraceptives containing drospirenone on hypothalamic-pituitary-adrenocortical axis activity and glucocorticoid receptor expression and function in women with polycystic ovary syndrome.
Hormones (Athens)
; 14(1): 109-17, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25402380
7.
Predictors of subclinical cardiovascular disease in women with polycystic ovary syndrome: interrelationship of dyslipidemia and arterial blood pressure.
Int J Endocrinol
; 2015: 812610, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25878664
Resultados
1 -
7
de 7
1
Próxima >
>>